Command Palette

Search for a command to run...

TORNTPHARM

₹3575-1.47%

Market Cap
₹1,20,456.12 Cr
Stock P/E
60.17
ROCE
27.32%
ROE
26.46%
Book Value
₹240.47

Financials

YoY Net Sales
EPS Growth
Operating Margin

You might have missed

CCI clears Torrent Pharma's proposal to buy stake in JB Chemicals

Business
1 week ago

CCI clears Torrent Pharma's proposal to buy stake in JB Chemicals

Business
2 weeks ago

J.B. Chemicals & Pharmaceuticals Open Offer: Corrigendum Issued

Other Updates
2 months ago

Shareholding

Holdings
Distribution
Promoter
Foreign Investors
Domestic Investors
Public

From Last Concall

POSITIVES
  • •
    Q1 FY26 revenue and EBITDA grew solidly with a healthy margin.
  • •
    India business shows durable momentum with mix drivers and ongoing MR expansion.
NEGATIVES
  • •
    Germany exposure remains a near-term headwind due to third-party supply issues.
  • •
    US profitability remains non-affirmative near term as investments continue.

Peers Summary

No Peers Data

Peer comparison data is not available for this stock.

Leveling the playing field in markets.

© 2025 EQHQ Technologies Pvt Ltd

"Information provided is for educational purposes only and not financial advice.

Explore
Watchlists